{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:01:56Z","timestamp":1788422516705,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-SUMMIT-108"],"award-info":[{"award-number":["AS-SUMMIT-108"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["MOST-108-3114-Y-001-002"],"award-info":[{"award-number":["MOST-108-3114-Y-001-002"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["MOST-107-0210-01-19-01"],"award-info":[{"award-number":["MOST-107-0210-01-19-01"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-CFII108-111"],"award-info":[{"award-number":["AS-CFII108-111"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-106-2314-B-002-103-MY2"],"award-info":[{"award-number":["MOST-106-2314-B-002-103-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2314-B-002-239"],"award-info":[{"award-number":["107-2314-B-002-239"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111584","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T19:41:20Z","timestamp":1564774880000},"page":"111584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of \u03b2-tubulin"],"prefix":"10.1016","volume":"181","author":[{"given":"Ming-Shiu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Ming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Hung","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuenn-Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chia","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Jen Rachel","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Huey","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Jie","family":"Chein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-6048","authenticated-orcid":false,"given":"Pan-Chyr","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111584_bib1","first-page":"7","article-title":"Cancer statistics","volume":"68","author":"Siegel","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2019.111584_bib2","first-page":"337","article-title":"First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors","volume":"6","author":"Nguyen","year":"2012","journal-title":"Biol. Targets & Ther."},{"key":"10.1016\/j.ejmech.2019.111584_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.lungcan.2010.08.022","article-title":"Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC","volume":"71","author":"Chang","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejmech.2019.111584_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2014.104","article-title":"Acquired resistance to TKIs in solid tumours: learning from lung cancer","volume":"11","author":"Camidge","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2019.111584_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.ejmech.2019.111584_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.cellbio.13.1.83","article-title":"Microtubule polymerization dynamics","volume":"13","author":"Desai","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2019.111584_bib7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00018-009-0245-6","article-title":"Microtubule targeting agents: from biophysics to proteomics","volume":"67","author":"Calligaris","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2019.111584_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122508","article-title":"Microtubule depolymerization by kinase inhibitors: unexpected findings of dual inhibitors","volume":"18","author":"Tanabe","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.111584_bib9","first-page":"65","article-title":"Targeting microtubules for cancer chemotherapy","volume":"5","author":"Zhou","year":"2005","journal-title":"Curr. Med. Chem. Anti Cancer Agents"},{"key":"10.1016\/j.ejmech.2019.111584_bib10","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1002\/jcp.27978","article-title":"Microtubules: from understanding their dynamics to using them as potential therapeutic targets","volume":"234","author":"Ilan","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2019.111584_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"A","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2019.111584_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbabio.2011.01.001","article-title":"Microtubule-targeted agents: when mitochondria become essential to chemotherapy","volume":"1807","author":"Rovini","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.111584_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1247\/csf.24.329","article-title":"Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators","volume":"24","author":"Wilson","year":"1999","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.ejmech.2019.111584_bib14","series-title":"Molecular Oncology: Underlying Mechanisms and Translational Advancements","first-page":"15","article-title":"Microtubule targeting agents in cancer therapy: elucidating the underlying molecular mechanisms","author":"Hasanpourghadi","year":"2017"},{"key":"10.1016\/j.ejmech.2019.111584_bib15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ejmech.2017.11.062","article-title":"Recent advances in microtubule-stabilizing agents","volume":"143","author":"Cao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111584_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2019.111584_bib17","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1038\/sj.onc.1206934","article-title":"Mechanisms of Taxol resistance related to microtubules","volume":"22","author":"Orr","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2019.111584_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2019.111584_bib19","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1158\/0008-5472.CAN-07-0509","article-title":"Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer","volume":"67","author":"Gan","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.111584_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.seminoncol.2008.02.010","article-title":"Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired","volume":"35","author":"Chien","year":"2008","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2019.111584_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","article-title":"Multiple drug resistance mechanisms in cancer","volume":"46","author":"Baguley","year":"2010","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.111584_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11864-012-0184-6","article-title":"Chemotherapy-resistant metastatic breast cancer","volume":"13","author":"Marquette","year":"2012","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejmech.2019.111584_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/476974","article-title":"Regulations of P-Glycoprotein\/ABCB1\/MDR1 in human cancer cells","volume":"2014","author":"Katayama","year":"2014","journal-title":"New J. Sci."},{"key":"10.1016\/j.ejmech.2019.111584_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2019.111584_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0092-8674(86)90595-7","article-title":"Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells","volume":"47","author":"Chen","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.111584_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","article-title":"The biochemistry of P-glycoprotein-mediated multidrug resistance","volume":"58","author":"Endicott","year":"1989","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2019.111584_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biopha.2018.02.038","article-title":"Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR","volume":"100","author":"Mohammad","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2019.111584_bib28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4161\/cbt.6.5.4006","article-title":"BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in\u00a0vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles","volume":"6","author":"Li","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejmech.2019.111584_bib29","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1038\/ncomms4155","article-title":"Diversity-oriented synthesis as a tool for identifying new modulators of mitosis","volume":"5","author":"Ibbeson","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.111584_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.111584_bib31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/onc.2012.133","article-title":"Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src\/nuclear EGFR cascade-activated DNA repair activity","volume":"32","author":"Lee","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2019.111584_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/17425255.2.5.753","article-title":"Therapeutic resistance in lung cancer","volume":"2","author":"Nadkar","year":"2006","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejmech.2019.111584_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nrm.2016.45","article-title":"Microtubules: 50 years on from the discovery of tubulin","volume":"17","author":"Borisy","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.111584_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2017.02.018","article-title":"Enhanced stability of microtubules contributes in the development of colchicine resistance in MCF-7 cells","volume":"132","author":"Rai","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111584_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3253","article-title":"Microtubule-binding agents: a dynamic field of cancer therapeutics","volume":"9","author":"Dumontet","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.111584_bib36","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1242\/jcs.039719","article-title":"How do anti-mitotic drugs kill cancer cells?","volume":"122","author":"Gascoigne","year":"2009","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2019.111584_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-16-0325","article-title":"A\u00a0novel structure class of mitotic inhibitor disrupting microtubule dynamics in prostate cancer cells","volume":"16","author":"Levrier","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2019.111584_bib38","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2019.111584_bib39","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1073\/pnas.0904223106","article-title":"Variations in the colchicine-binding domain provide insight into the structural switch of tubulin","volume":"106","author":"Dorleans","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2019.111584_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jss.2004.11.017","article-title":"Colchicine and 2-methoxyestradiol inhibit human angiogenesis","volume":"125","author":"Stafford","year":"2005","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.ejmech.2019.111584_bib41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2613.2009.00651.x","article-title":"Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies","volume":"90","author":"Kanthou","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejmech.2019.111584_bib42","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.bjc.6605489","article-title":"Class III beta-tubulin expression and in\u00a0vitro resistance to microtubule targeting agents","volume":"102","author":"Stengel","year":"2010","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2019.111584_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000489983","article-title":"SKLB060 reversibly binds to colchicine site of tubulin and possesses efficacy in multidrug-resistant cell lines","volume":"47","author":"Yan","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2019.111584_bib44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2018.04.011","article-title":"Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site","volume":"151","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111584_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2019.111584_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2019.111584_bib47","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111584_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/DTI.S12519","article-title":"P-glycoprotein inhibition for optimal drug delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.ejmech.2019.111584_bib49","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1200\/JCO.2007.12.6557","article-title":"Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment","volume":"25","author":"Thomas","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2019.111584_bib50","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1634\/theoncologist.2008-0143","article-title":"Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors","volume":"13","author":"Rivera","year":"2008","journal-title":"The Oncologist"},{"key":"10.1016\/j.ejmech.2019.111584_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1165\/ajrcmb.17.3.2837","article-title":"Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line","volume":"17","author":"Chu","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.111584_bib52","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:51:16Z","timestamp":1778676676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419307184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":52,"alternative-id":["S0223523419307184"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111584","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of \u03b2-tubulin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111584"}}